270 related articles for article (PubMed ID: 16822086)
21. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
Moroni M; Veronese S; Schiavo R; Carminati O; Sorensen BS; Gambacorta M; Siena S
Clin Cancer Res; 2001 Sep; 7(9):2770-5. PubMed ID: 11555591
[TBL] [Abstract][Full Text] [Related]
22. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.
Boerboom D; Paquet M; Hsieh M; Liu J; Jamin SP; Behringer RR; Sirois J; Taketo MM; Richards JS
Cancer Res; 2005 Oct; 65(20):9206-15. PubMed ID: 16230381
[TBL] [Abstract][Full Text] [Related]
23. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
Wu R; Hendrix-Lucas N; Kuick R; Zhai Y; Schwartz DR; Akyol A; Hanash S; Misek DE; Katabuchi H; Williams BO; Fearon ER; Cho KR
Cancer Cell; 2007 Apr; 11(4):321-33. PubMed ID: 17418409
[TBL] [Abstract][Full Text] [Related]
24. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
25. High-throughput microRNAome analysis in human germ cell tumours.
Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
[TBL] [Abstract][Full Text] [Related]
26. Expression of glypican 3 in ovarian and extragonadal germ cell tumors.
Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ
Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.
Mándoky L; Géczi L; Doleschall Z; Bodrogi I; Csuka O; Kásler M; Bak M
Anticancer Res; 2004; 24(2C):1097-104. PubMed ID: 15154630
[TBL] [Abstract][Full Text] [Related]
28. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development.
Honecker F; Kersemaekers AM; Molier M; Van Weeren PC; Stoop H; De Krijger RR; Wolffenbuttel KP; Oosterhuis W; Bokemeyer C; Looijenga LH
J Pathol; 2004 Oct; 204(2):167-74. PubMed ID: 15378486
[TBL] [Abstract][Full Text] [Related]
29. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma.
Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507
[TBL] [Abstract][Full Text] [Related]
30. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
31. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.
Shedden KA; Kshirsagar MP; Schwartz DR; Wu R; Yu H; Misek DE; Hanash S; Katabuchi H; Ellenson LH; Fearon ER; Cho KR
Clin Cancer Res; 2005 Mar; 11(6):2123-31. PubMed ID: 15788657
[TBL] [Abstract][Full Text] [Related]
32. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
[TBL] [Abstract][Full Text] [Related]
33. Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells.
Rider V; Isuzugawa K; Twarog M; Jones S; Cameron B; Imakawa K; Fang J
J Endocrinol; 2006 Dec; 191(3):537-48. PubMed ID: 17170212
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
35. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors.
Korkola JE; Houldsworth J; Chadalavada RS; Olshen AB; Dobrzynski D; Reuter VE; Bosl GJ; Chaganti RS
Cancer Res; 2006 Jan; 66(2):820-7. PubMed ID: 16424014
[TBL] [Abstract][Full Text] [Related]
37. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
Surendran K; Schiavi S; Hruska KA
J Am Soc Nephrol; 2005 Aug; 16(8):2373-84. PubMed ID: 15944336
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
[TBL] [Abstract][Full Text] [Related]
39. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
40. Identification of transcriptional targets of Wnt/beta-catenin signaling in dermal papilla cells of human scalp hair follicles: EP2 is a novel transcriptional target of Wnt3a.
Shin H; Kwack MH; Shin SH; Oh JW; Kang BM; Kim AA; Kim J; Kim MK; Kim JC; Sung YK
J Dermatol Sci; 2010 May; 58(2):91-6. PubMed ID: 20347274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
